Related Experiment Video
Updated: Jun 29, 2026

Modifying Levels of Maternal Dietary Folic Acid or Choline to Study the Impact of Deficiencies on Offspring Health Outcomes
Published on: June 28, 2024
Progressive encephalopathy in a child with cerebral folate deficiency syndrome
Joshua L Bonkowsky1, Vincent T Ramaekers, Edward V Quadros
1Department of Pediatrics, Division of Pediatric Neurology, University of Utah School of Medicine, Salt Lake City, Utah 84108, USA. joshua.bonkowsky@hsc.utah.edu
Insights
Cerebral folate deficiency syndrome, linked to folate receptor autoantibodies, can cause developmental delay and seizures. Early diagnosis is crucial for managing this rare neurological condition.
Area of Science:
- Neurology
- Pediatrics
- Metabolic Disorders
Background:
- Cerebral folate deficiency syndrome (CFDS) is a rare neurological disorder.
- It is characterized by developmental delay, regression, and seizures.
- CFDS is associated with autoantibodies targeting folate receptors.
Observation:
- A case study of a female child with developmental delay and seizures is presented.
- The child experienced unexplained coma and subsequent developmental regression.
- Initial extensive testing did not reveal the cause.
Findings:
- Cerebrospinal fluid analysis revealed low methyltetrahydrofolate levels.
- Elevated autoantibodies against folate receptors were subsequently identified.
- These findings confirmed the diagnosis of CFDS.
Implications:
- This case highlights the importance of considering CFDS in children with unexplained neurological symptoms.
- Early diagnosis and intervention are critical for managing CFDS.
- Despite treatment with folinic acid, the patient developed intractable epilepsy and severe developmental delay, underscoring the challenges in managing advanced cases.
Abstract:
Cerebral folate deficiency syndrome, a recently recognized cause of developmental delay, regression, and seizures, is associated with autoantibodies against folate receptors. A female child with developmental delay and a history of seizures who presented with seizures and unexplained coma is reported. Extensive testing to evaluate the patient's coma and subsequent developmental regression were unrevealing until the results of her cerebrospinal fluid neurotransmitter analysis returned. These showed low levels of methyltetrahydrofolate, the active metabolite of folate in the cerebrospinal fluid; subsequently, elevated titers of autoantibodies against folate receptors were found. Despite treatment with folinic acid, she developed intractable epilepsy and severe developmental delay.
More Related Videos
Related Concept Videos
Hepatic Encephalopathy
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology
Cerebral Edema ll: Pathophysiology
Rocky Mountain Spotted Fever
Vitamins

